Higher concentrations of specific polychlorinated biphenyl congeners in adipose tissue from non-Hodgkin's lymphoma patients compared with controls without a malignant disease

International Journal of Oncology

Volumn 9, Issue 4, 1996, Pages 603-608

  Hardell, Lennart ^a   Van Bavel, Bert ^b   Lindström, Gunilla ^b   Fredrikson, Mats ^c   Hagberg, Hans ^d   Liljegren, Göran ^a   Nordström, Marie ^a   Johansson, Bengt ^a  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

case control study; non Hodgkin's lymphoma; organochlorines; polychlorinated biphenyls

Indexed keywords

POLYCHLORINATED BIPHENYL;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TISSUE LEVEL;

EID: 0029838404     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.4.603     Document Type: Article

References (38)

1. Hardell L: Malignant lymphoma of histiocytic type and exposure to phenoxyacetic acids or chlorophenols. Lancet ii: 55, 1979.
2. Hardell L, Eriksson M, Lenner P and Lundgren E: Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids; A case-control study. Br J Cancer 43: 169-176, 1981.
3. Hoar Zahm S and Blair A: Pesticides and non-Hodgkin lymphoma. Cancer Res 52: 5485-5488, 1992.
4. Hardell L, Eriksson M and Degerman A: Exposure to phenoxyacetic acids, chlorophenols, or organic solvents in relation to histopathology, stage, and anatomical localization of non-Hodgkin's lymphoma. Cancer Res 54: 2386-2389, 1994.
5. Hardell L, Eriksson M, Axelson O and Hoar Zahm S: Cancer epidemiology. In: Dioxins and Health. Scheeler A (ed). Plenum Press, New York, pp525-547, 1994.
6. Persson B, Dahlander AM, Fredriksson M, Noorlind Brage H, Ohlson CG and Axelson O: Malignant lymphomas and occupational exposure. Br J Ind Med 46: 516-520, 1989.
7. Persson B, Fredriksson M, Olsen K, Boeryd B and Axelson O: Some occupational exposures as risk factors for malignant lymphomas. Cancer 72: 1773-1778, 1993.
8. Hoar SK, Blair A, Holmes FF, Boysen CD, Robel RJ, Hoover R and Fraumeni JF Jr: Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. J Am Med Assoc 256: 1141-1147, 1986.
9. Hoar Zahm S, Weisenburger DD, Babbitt PA, Saal RC, Vaught JB, Cantor KP and Blair A: A case-control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in Eastern Nebraska. Epidemiology 1: 349-356, 1990.
10. Tucker AN, Vore SJ and Luster MI: Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 29: 372-377, 1986.
11. Sharma RP and Reddy RV: Toxic effects of chemicals on the immune system. In: Handbook of Toxicology. Haley TJ (ed). Hemisphere Pub Corp., Washington DC, pp555-591, 1987.
12. Dobson S and van Esch GJ (eds): Polychlorinated Biphenyls and Terpehnyls (2nd Edition). Environmental Health Criteria 140, World Health Organization, Geneva, pp423-435, 1993.
13. Filipovich AH, Mathur A, Kamat D and Shapiro RS: Primary immunodeficiencies. Genetic risk factor for lymphoma. Cancer Res 52: 5465-5467, 1992.
14. Kinlen LJ, Sheil AGR, Peto J and Doll R: Collaborative United Kingdom-Australian study of cancer in patients treated with immunosuppressive drugs. Br Med J ii: 1461-1477, 1979.
15. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, Gill PS, Burkes RL, Meyer PR, Metroka CE, Mouradian J, Moore A, Riggs SA, Butler JJ, Cabanillas FC, Hersh E, Newell GR, Laubenstein LJ, Knowles D, Odanjnyk C, Raphael B, Koziner B, Urmacher C and Clarkson B: Non-Hodgkin's lymphoma in 90 homosexual men: relationship to generalized lymphadenopathy and acquired immunodeficiency syndrome. N Engl J Med 311: 565-570, 1984.
16. Kinlen L: Immunosuppressive therapy and acquired immunological disorders. Cancer Res 52: 5474-5476, 1992.
17. Opelz G and Henderson R: For the colloborative transplant study. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipient. Lancet 342: 1514-1516, 1993.
18. Hardell L, Fredrikson M, Eriksson M, Hansson M and Rappe C: Adipose tissue concentrations of dioxins and dibenzofurans in patients with malignant lymphoproliferative diseases and in patients without a malignant disease. Eur J Cancer Prev 4: 225-229, 1995.
19. Kripke ML: Effects of UV radiation on tumor immunity. J Natl Cancer Inst 82: 1392-1396, 1990.
20. Grabbe S and Granstein RD: .Mechanisms of ultraviolet radiation carcinogenesis. In: Mechanisms of Immune Regulation. Granstein RD (ed). Chem Immunol, Basel, Karger (vol 58)pp291-313, 1994.
21. Blumberg N and Heal JM: Transfusion-associated immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection. Yale J Biol Med 63:429-433, 1990.
22. Blomberg J, Möller T, Olsson H, Anderson H and Jonsson M: Cancer morbidity in blood recipients - results of a cohort study. Eur J Cancer 29A: 2101-2105, 1993.
23. Cerhan JE, Wallace RB, Folsom AR, Potter JD, Munger RG and Pineas RJ: Transfusion history and cancer risk in older women. Ann Intern Med 119: 8-15, 1993.
24. Van Bavel B, Järemo M, Karlsson L and Lindström G: Development of a solid phase carbon trap for simultaneous determination of PCDDs, PCDFs, PCBs, and pesticides in environmental samples using SFE-LC. Anal Chem 68: 1279-1283, 1996.
25. Hardell L and Eriksson M: Non-Hodgkin lymphoma and previous exposure to hexachlorophene: a case report. J Occup Med 34: 849-850, 1992.
26. Bertazzi PA, Pesatori AC, Consonni D, Tironi A, Landi MT and Zocchetti C: Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin. Epidemiology 4: 398-406, 1993.
27. Fingerhut MA, Halperin WE, Marlow DA, Piacitelli LA, Honchar PA, Sweeney MH, Greife AL, Dill PA, Steenland K and Suruda AJ: Cancer mortality in workers exposed to 2,3,7,8tetrachlorodibenzo-p-dioxin. N Engl J Med 324: 212-218, 1991.
28. Manz A, Berger J, Dwyer JH, Flesch-Janys D, Nagel S and Waltsgott H: Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet 338: 959-964, 1991.
29. Collins JJ, Strauss ME, Levinskas GJ and Conner PR: The mortality experience of workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a trichlorophenol process accident. Epidemiology 4: 7-13, 1993.
30. Zober A, Messerer P and Huber P: Thirty-four-year mortality follow-up of BASF employees exposed to 2,3,7,8-TCDD after the 1953 accident. Int Arch Occup Environ Health 62: 139-157, 1990.
31. Dobson S and van Esch GJ (eds): Polychlorinated Biphenyls and Terpehnyls (2nd Edition). Environmental Health Criteria 140, World Health Organization, Geneva, pp379-392, 1993.
32. Lu YC and Wu YC: Clinical findings and immunological abnormalitcs in Yu-Cheng patients. Environ Health Perspect 59: 17-29, 1985.
33. Nakanishi Y, Shigematsu N, Kurita Y, Matsuba K, Kanegae H, Ishimura S and Kawazoe Y: Respiratory involvement and immune status in Yusho patients. Environ Health Perspect 59: 31-36, 1985.
34. Bertazzi PA, Zochetti C, Guercilena S, Foglia MD, Pesatori A and Riboldi L: Cancer mortality of capacitor manufacturing workers. Am J Ind Med 11: 165-176, 1987.
35. Brown DP: Mortality of workers exposed to polychlorinated biphenyls - an update. Arch Environ Health 42: 333-339, 1987.
36. Wolff MS, Anderson HA and Selikoff IJ: Human tissue burdens of halogenated aromatic chemicals in Michigan. J Am Med Assoc 247: 2112-2115, 1982.
37. Wolff MS: Pesticides - how research has succeeded and failed in informing policy: DDT and the link with breast cancer. Environ Health Perspect 103: 87-91, 1995.
38. Dahl P, Lindström G, Wiberg K and Rappe C: Absorption of polychlorinated biphenyls, dibenzo-p-djoxins and dibenzofurans by breast-fed infants. Chemosphere 30: 2297-2306, 1995.